Chart Review of Outcome of Treatment for S. Aureus Bacteremia

Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia

NCT06574399 ·Status: RECRUITING

Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia

NCT06695832 ·Status: ACTIVE_NOT_RECRUITING

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus

NCT04503252 ·Status: COMPLETED

Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus

NCT04469348 ·Status: COMPLETED ·Phase: NA

Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection

NCT00911430 ·Status: TERMINATED

Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus

NCT05889351 ·Status: COMPLETED ·Phase: PHASE2

Antimicrobial Drug Use and Resistant Staphylococcus Aureus

NCT01075451 ·Status: COMPLETED

Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology

NCT01971762 ·Status: COMPLETED

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

NCT01049438 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)

NCT01324440 ·Status: COMPLETED ·Phase: PHASE1

Staphylococcus Aureus Caught in Action at the Site of Infection

NCT04781569 ·Status: COMPLETED

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

NCT05184764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Human Immunity Against Staphylococcus Aureus Skin Infection

NCT02262819 ·Status: COMPLETED ·Phase: PHASE1

Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

NCT04160468 ·Status: TERMINATED ·Phase: PHASE3

Study of the Efficacy and Safety of MEDI4893

NCT02296320 ·Status: COMPLETED ·Phase: PHASE2

Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity

NCT05522764 ·Status: UNKNOWN

Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne

NCT02557568 ·Status: COMPLETED ·Phase: NA

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

NCT03489629 ·Status: COMPLETED ·Phase: PHASE2

S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues

NCT04666532 ·Status: UNKNOWN

ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis

NCT05329168 ·Status: WITHDRAWN ·Phase: PHASE2

Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses

NCT02690415 ·Status: COMPLETED

A Study to Investigate the Transmission and Burden of PVL-MRSA in Households in Sri Lanka

NCT04884958 ·Status: UNKNOWN

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

NCT01640886 ·Status: TERMINATED

Recurrent S. Aureus Infections in Osteoarticular Infections

NCT04712123 ·Status: UNKNOWN

NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis

NCT04257292 ·Status: UNKNOWN